28
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Fine-Mapping of the Mouse T Lymphocyte Fraction (Tlf) Locus on Chromosome 9: Association with Autoimmune Diabetes

Pages 31-45 | Received 30 Sep 1997, Published online: 07 Jul 2009

References

  • Pearce R., Formby B., Healy K., Peterson C. Association of an androgen-responsive T cell phenotype with murine diabetes and Idd2. Autoimmunity 1995; 20: 247–258
  • Todd J., Aitman T., Cornall R., Ghosh S., Hall J., Hearne C., Knight A., Love J., McAleer M., Prins J., Rodrigues N., Lathrop M., Pressey A., DeLarato N., Peterson L., Wicker L. Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature 1991; 351: 542–547
  • McAleer M., Reifsnyder P., Palmer S., Prochazka M., Love J., Copeman J., Powell E., Rodrigues N., Prins J., Scrreze D., DeLarato N., Wicker L., Peterson L., Schork N., Todd J., Leiter E. Crosses of NOD mice with the related NON strain: A polygenic Model for IDDM. Diabetes 1995; 44: 1186–1195
  • Cornall R., Prins J., Todd J., Pressey A., DeLarato Wicker L., Peterson L. Type 1 diabetes in mice is linked to the interleukin-1 receptor and Lsh/lty/Bcg, genes on Chromosome 1. Nature 1991; 353: 262–265
  • Chesnut K., She J., Cheng I., Muralidharan K., Wakeland E. Characterizations of candidate genes for IDD susceptibility from the diabetes-prone NOD mouse strain. Mammalian Genome 1993; 4: 549–554
  • Prins J., Todd J., Rodrigues N., Ghosh S., Hogarth P., Wicker L., Gaffner E., Podolin P., Fischer P., Sirotina A., Peterson L. Linkage on Chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice. Science 1993; 260: 695–698
  • Morahan G., McClive P., Huang D., Little P., Baxter A. Genetic and physiological association of diabetes susceptibility with raised Na+/H+ exchange activity. PNAS, (USA) 1994; 91: 5898–5902
  • Rothe H., Jenkins N., Copeland N., Kolb H. Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near ldd2. J. Clinical Investig 1997; 99: 469–74
  • Davies J., Yoshihiko K., Bennett S., Copeman J., Cordell H., Pritchard L., Reed P., Gough S., Jenkins S., Palmer S., Balfour K., Rowe B., Farrall M., Barnett A., Bain S., Todd J. A genome-wide search for human type I diabetes susceptibility genes. Nature 1994; 371: 130–135
  • Krug J., Williams A., Beales P., Doniach I., Gale E., Pozzilli P. Parathyroiditis in the non-obese diabetic mouse – a new finding. Journal of Endocrinology 1991; 131: 193–196
  • Baxter A., Mandel T. Hemolytic anemia in non-obese diabetic mice. European Journal of Immunology 1994; 21: 2051–2055
  • Ridgway W., Fasso M., Lanctot A., Garvey C., Fathman C. Breaking self-tolerance in nonobese diabetic mice. J. Exp. Med. 1996; 183: 1657–1662
  • Asamoto H., Oishi M., Akazawa Y., Tochino Y. Histological and immunological changes in the thymus and other organs in NOD mice. Insulitis and Type 1 diabetes – Lessons from the NOD Mouse, S. Trui, Y. Tochino, K. Nonaka. Academic Press, Tokyo 1986; 61
  • Fox H. S. Androgen treatment prevents diabetes in nonobese diabetic mice. J. Exp. Med. 1992; 175: 1409–1412
  • Beeson P. Age and Sex associations of 40 autoimmune diseases. The American J. Medicine 1994; 96: 457–462
  • Prochazka M., Leiter E., Serreze D., Coleman D. Three recessive loci required for insulin-dependent diabetes in nonobese diabetice mice. Science 1987; 237: 286–289
  • Kruglyak L., Lander E. A nonparametric approach for mapping quantitative trait loci. Genetics 1995; 139: 1421–1428
  • Bellacosa A., Datta K., Bear S., Patriotis C., Lazo P., Copeland N., Jenkins N., Tsichlis P. Effects of provirus integration in the Tpl-I/Ets-I locus in Moloney murine leukemia virus-induced rat T-cell lymphomas: levels of expression, polyadenylation, transcriptional initiation, and differential splicing of the Ets-ImRNA. Journal of Virology 1994; 68: 2320–30
  • Hattori M., Yamato E., Hirokawa K., Petruzelli M., Makino S., Chapman V. Male backcross mice of NOD with Mus spretus, Spain predominantly develop diabetes regardless of MHC homozygosity and heterozygosity. Diabetes 1992; 41: 93A
  • Allison J., McClive P., Oxbrow L., Baxter A., Morahan G., Miller J. Genetic requirements for acceleration of diabetes in non-obese diabetic mice expressing interleukin-2 in islet b-cells. European Journal of Immunology 1994; 24: 2535–2541
  • Mori N., Okumoto M., Hart A., Demant P. Apoptosis susceptibility genes on mouse Chromosome 9 (Rapop2,) and Chromosome 3 (Rapop3,). Genomics 1995; 30: 553–557
  • Garchon H., Luan J., Eloy L., Bedossa P., Bach J. Genetic analysis of immune dysfunction in non-obese diabetic (NOD) mice: mapping of a susceptibility locus close to the Bcl-2, gene correlates with increased resistance of NOD T cells to apoptosis induction. European Journal of Immunology 1994; 24: 380–384
  • Penha-Goncalves C., Leijon K., Persson L., Holmberg D. Type 1 diabetes and the control of dexamethazone-induced apoptosis in mice maps to the same region of Chromosome 6. Genomics 1995; 28: 398–404
  • Zipris D., Crow A., Delvovitch T. Altered thymic and peripheral T lymphocyte repertoire preceding onset of diabetes in NOD mice. Diabetes 1991; 40: 429–435
  • Baker D., Rosenwasser O., O'Neill J., Turk J. Genetic analysis of experimental allergic encephalomyelitis in mice. J. Immunol 1995; 155: 4046–4051
  • Romano-Spica V., Georgiou P., Suzuki H., Papas T., Bhat N. Role of ETS1, in IL-2 gene expression. J. Immunol 1995; 154: 2724–2732
  • Bassuk A., Leiden T. A direct physical association between ETS and AP-1 transactivating factors in normal T cells. Immunity 1995; 3: 233–237
  • Ho I., Narayan B., Gottschalk L., Lindsten T., Thompson C., Papas T., Leiden J. Sequence-specific binding of human Ets-1 to the T cell receptor alpha gene enhancer. Science 1990; 250: 814–817
  • Roussel M. Signal induction by the macrophage-colony stimulating factor receptor (CSF-IR). J. Cell Sci., (Supp 18) 1994; 105–108
  • Grant P., Andersson T., Neurath M., Arulanpalan V., Bauch A., Muller R., Reth M., Pettersson S. A T cell controlled molecular pathway regulating the IgH locus: CD40-mediated activation of the IgH 3′ enhancer. Embo 1996; 15: 6691–6700
  • Gunther C., Nye J., Bryner R., Graves B. Sequence-specific DNA binding of the proto-oncogene ets-1, defines a transcriptional activator sequence within the long terminal repeat of the Moloney murine sarcoma virus. Genes and Development 1990; 4: 667–679
  • Kramer B., Wiegmann K., Krönke M. Regulation of the human TNF promoter by the transcription factor Ets. J. Biol. Chem 1995; 270: 6577–6583
  • Wicker L., Miller B., Chai A., Terada M., Mullen Y. Expression of genetically determined diabetes and insulitis in the nonobese diabetic (NOD) mouse at the level of bone marrow-derived cells. Transfer of diabetes and insulitis to nondiabetic (NOD × B10)F1 mice with bone marrow cells from NOD mice. J. Exp. Med. 1988; 167: 1801–1810
  • Serreze D., Leiter E. Transplantation analysis of B cell destruction in (NOD × CBA)FI mouse bone marrow chimeras. Diabetologia 1990; 33: 84–92
  • Zhang L., Eddy A., Teng Y. T., Fritzler M., Kluppel M., Melet F., Bernstein A. An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes. Molecular and Cellular Biology 1995; 15: 6961–70
  • Melet F., Motro B., Rossi D. J., Zhang L., Bernstein A. Generation of a novel Fli-1 protein by gene targeting leads to a defect in thymus development and a delay in Friend virus-induced erythroleukemia. Molecular and Cellular Biology 1996; 16: 2708–18
  • Bories J., Willerford D., Grévin D., Davidson L., Camus A., Martin P., Stéhelin, Alt F. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 protooncogene. Nature 1995; 377: 635–638
  • Muthusamy N., Barton K., Leiden J. Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature 1995; 377: 639–642
  • Georgiou P., Chen S., Suzuki H., Romano-Spica V., Lautenberger J., Papas T., Bhat N. Expression of ets, family genes in systemic lupus erythematosus. Advances in Gene Technology: Protein Engineering and Structural Biology 1995; 8: S34
  • Dooley S., Herlitzka I., Hanselmann R., Ermis A., Henn W., Remberger K., Hopf T., Welter C. Constitutive expression of c-fos, and c-jun, overexpression of ETS-2, and reduced expression of metastasis suppressor gene nm23-H1 in rheumatoid arthritis. Annals of the Rheumatic Diseases 1996; 55: 298–304
  • Aparicio J., Wakisaka A., Takada A., Matsuura N., Yoshiki T. Non-HLA genetic factors and insulin dependent diabetes mellitus in the Japanese: TCRA, TCRB, and TCRG, INS, THY1, CD3D, and ETS1. Disease Markers 1990; 8: 283–294
  • Satoh J., Shintani S., Nobunaga T., Sugawara S., Makino S., Toyota T., Goto Y. NOD mice with high incidence of type 1 diabetes are not T lymphopenic. Tohoku J. Exp. Med. 1988; 15: 151–158
  • Ilonen J., Surcel H., Käär M. Abnormalities within CD4 and CDS T lymphocyte subsets in type 1 (insulin-dependent) diabetes. Clin. Exp. Immunol 1991; 85: 278–281

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.